BIOPHYTIS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.666 EUR | -0.67% |
|
-3.48% | -67.35% |
| May. 14 | Biophytis unveils design for obesity study | CF |
| May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
| Sales 2024 * | - | Sales 2025 * | 4.8M 5.23M | Capitalization | 1.92M 2.09M |
|---|---|---|---|---|---|
| Net income 2024 * | -19M -20.69M | Net income 2025 * | -16M -17.42M | EV / Sales 2024 * | - |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.4 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
More Fundamentals
* Assessed data
More press releases
| 1 day | -1.38% | ||
| 1 week | -4.20% | ||
| Current month | -2.83% | ||
| 1 month | -21.12% | ||
| 3 months | -58.09% | ||
| 6 months | -68.37% | ||
| Current year | -67.13% |
1 week
0.67
0.70
1 month
0.630.90
Current year
0.632.24
1 year
0.6312.80
3 years
0.63423.80
5 years
0.631 092.00
10 years
0.637 720.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 0.666 | -0.67% | 8 738 |
| 24-06-06 | 0.6705 | -1.38% | 10,453 |
| 24-06-05 | 0.6799 | +1.45% | 9,978 |
| 24-06-04 | 0.6702 | -1.74% | 27,178 |
| 24-06-03 | 0.6821 | -1.14% | 12,524 |
Real-time Euronext Paris, June 06, 2024 at 11:35 am EDT
More quotes
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
Calendar
2024-10-28
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -67.13% | 2.09M | |
| +19.33% | 125B | |
| +13.95% | 108B | |
| -3.53% | 24.57B | |
| +2.71% | 22.82B | |
| -9.95% | 18.19B | |
| -41.48% | 16.54B | |
| -12.62% | 16.5B | |
| +0.99% | 13.39B | |
| +21.79% | 11.1B |
- Stock Market
- Equities
- ALBPS Stock
